This is a beginner’s course for mechanistic modelers, pharmacologists, clinicians, pharmaceutical/biotechnology scientists, and engineers in the specific area of clinical and quantitative systems pharmacology (QSP) for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Prior experience with IPFsym or ILDsym is not required. The course will focus on IPFsym v1A and ILDsym v1A, but many of the guiding principles will be taught in a software-independent manner. Class size is limited to encourage interaction with the course instructors and among attendees. Virtual networking among industry, government, and academic scientists is part of the experience!